NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Monkeypox Treatment for Monkeypox virus; Adenovirus 71 Treatment for severe pediatric hepatitis caused by Adenovirus 71 or related viruses; and HerpeCide Program Expansion Drug project that develops broad-spectrum nanoviricide drugs against different herpes viruses for different indications. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. The company was founded in 2005 and is based in Shelton, Connecticut.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [12/02/2025 06:49 PST] NNVC Expected to Trade Up After Bullish Patterns Develop
• [12/01/2025 06:58 PST] NNVC Expected to Trade Up After Bullish Patterns Develop
• [11/19/2025 06:50 PST] NNVC Expected to Trade Up After Bullish Patterns Develop
• [11/17/2025 07:05 PST] NNVC Expected to Trade Up After Bullish Patterns Develop
• [11/13/2025 13:20 PST] NanoViricides, Inc. (NYSE:NNVC), Down By 100% ($1.59) From $1.59 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [11/12/2025 06:51 PST] NNVC Expected to Trade Down After Bearish Patterns Develop
• [11/03/2025 15:33 PST] NanoViricides, Inc. (NYSE:NNVC), Up By 100% ($1.61) From $1.61 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [10/29/2025 10:29 PDT] NanoViricides, Inc. (NYSE:NNVC), Up By 100% ($1.43) From $1.43 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [10/28/2025 06:55 PDT] NNVC Expected to Trade Up After Bullish Patterns Develop
• [10/09/2025 07:25 PDT] NNVC Expected to Trade Up After Bullish Patterns Develop
• [10/08/2025 07:09 PDT] NNVC Expected to Trade Up After Bullish Patterns Develop